US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for Leishmaniasis (Kala-Azar), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Gouty Arthritis (Gout) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Gouty Arthritis (Gout), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Colitis - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Payer Insights: Hepatitis C
9/26/2014 | published by: FirstWord
... healthcare payers in the US, is packed with hard-hitting, candid opinions and advice on how, from their perspective, Pharma can get it right in the future. Gilead’s commercial success with its ground breaking HCV treatment ...  |  read more...
USD 6,495
Genital Herpes - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
... therapeutic development for Genital Herpes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Bile Duct Cancer (Cholangiocarcinoma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... overview of the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer), complete with ...  |  read more...
USD 2,000
H3N2 Infection - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for H3N2 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Metastatic Hepatocellular Carcinoma (HCC), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Pruritus - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... Pruritus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Cancer Cachexia - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for Cancer Cachexia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Corneal Neovascularization - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for Corneal Neovascularization, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Ebola Viral Infections - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Ebola Viral Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting
9/15/2014 | published by: GBI Research
... Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting’, which provides in-depth insights into the indication. It gives an estimation of market size for 2013 along with forecasts until 2020 for ...  |  read more...
USD 4,995
Arrhythmias - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... Arrhythmias, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Venous Thromboembolism - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic development for Venous Thromboembolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments (HPLC, Mass Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) & by End User - Global Forecast to 2019
9/30/2014 | published by: MarketsandMarkets
... and carbohydrate-containing biomolecules in biological processes such as cell recognition, immune response, cell-to-cell interaction, infection and inflammation. These processes are dependent on the intricate glycan structures present on interacting biomolecules. Advanced technologies such as high-throughput ...  |  read more...
USD 4,650
Thrombosis Global Clinical Trials Review, H2, 2014
9/30/2014 | published by: GlobalData
... relating to the clinical trials on Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Hairy Cell Leukemia - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
... information on the therapeutic development for Hairy Cell Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Metastatic Ovarian Cancer - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... information on the therapeutic development for Metastatic Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Global Pancreatic Cancer Market : 2014-2018
10/1/2014 | published by: TechNavio - Infiniti Research Ltd.
... endocrine pancreatic cancer. When pancreatic cancer cells spread from the pancreas to other parts of the body, it is known as metastatic pancreatic order. The incidence and mortality rate of pancreatic cancer is higher in ...  |  read more...
USD 2,500
Global Premature Ejaculation Market : 2014-2018
10/1/2014 | published by: TechNavio - Infiniti Research Ltd.
... the average time taken by a man to ejaculate during sexual intercourse. There are two types of premature ejaculation: Primary premature ejaculation and secondary premature ejaculation. TechNavio's analysts forecast the Global Premature Ejaculation market to ...  |  read more...
USD 2,500
Polycystic Ovarian Syndrome - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... information on the therapeutic development for Polycystic Ovarian Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Heart Attack - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic development for Heart Attack, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Epidermolysis Bullosa - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
... therapeutic development for Epidermolysis Bullosa, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
1    3    5  6  7  8  9  10